Search Kailos website
Order your Information is Power test directly with the unique code obtained from the Hudson Alpha Institute for Biotechnology.
Kailos Genetics offers a complete sequencing solution that includes every reagent or service your research laboratory requires, from assay design to data analysis and everything in between. We will coordinate with your organization to develop a hereditary cancer and/or pharmacogenomic next generation sequencing plan that works for your particular application with as much or as little support as you need.
Contact us below to find out how we can generate a successful sequencing solution for your laboratory.
Kailos Genetics is an industry-leading clinical laboratory equipped to meet all of your pharmacogenomics testing needs. Our CAP-accredited laboratory uses next generation DNA sequencing to provide the most complete, accurate and transparent pharmacogenetics information, delivered in your preferred format for easy integration into your health information system.
Current DNA sequencing methods identify changes in important pharmacogenes to provide insights into medication metabolism that were previously unattainable. Our non-invasive sample collection method, rapid turnaround times, multiple reporting options and affordable rates are designed...
May 4, 2021
As our DNA sequencing capabilities and understanding of genetic diseases improves over time, our ability to predict genetic disease also improves.
Our Expedio™ Hereditary Cancer and Inspexion™ Pharmacogenetics tests are physician-directed genetic screenings that offer a cost-effective strategy designed to achieve optimized, personalized care for your patients.
Designed around evidence-based guidelines and recommendations from leading genetic healthcare experts, Kailos Prevent™ can identify DNA changes with significant potential for positive impact on a person's health. These genetic changes increase the risk of developing cancer, heart disease, strokes and the metabolism of antidepressants & opioids.